PROMETHEUS^® IBS Diagnostic is the First Blood-Based Biomarker Test for IBS

Welcome to the PROMETHEUS IBS website for patients. Here you can learn more about irritable bowel syndrome (IBS), a common disorder that affects as many as 20% of the adult population in the United States. Although IBS is not considered life threatening, untreated symptoms such as abdominal pain, constipation and diarrhea, can disrupt a patient's personal, social, and work-related activities. Prometheus is a specialty pharmaceutical company committed to improving the lives of patients. Prometheus primarily focuses on the treatment, diagnosis and detection of gastrointestinal, autoimmune and inflammatory disease and disorders.

The symptoms of IBS may seem similar to those of other gastrointestinal disorders, such as inflammatory bowel diseases (ulcerative colitis or colitis and Crohn's disease) and celiac disease. Although IBS is often confused with ulcerative colitis or colitis, there are important differences.

Getting the right diagnosis is the first step to getting help for IBS symptoms and restoring a full, active lifestyle. There are now many resources available for you to get help for IBS, including a test your doctor can give you called PROMETHEUS IBS Diagnostic that helps diagnose IBS and rule out other bowel disorders.

For Healthcare Professionals